Christine Lind
Directeur Général chez BACTIGUARD HOLDING AB
Fortune : 40 480 $ au 30/06/2024
Profil
Christine Lind is currently the Chairman & Chief Executive Officer at Lind Growth Strategy AB, the Chief Executive Officer at Bactiguard Holding AB, the Chairman at Mendus AB, an Independent Director at Xspray Pharma AB, and the Senior Vice President-Commercial at NDA Group AB.
She previously held positions as a Director at Medivir Personal AB and Glycovisc BioTech AB, Vice President-Business Development at LifeCell Corp., Head-Strategic Business Development at Medivir AB, and Head-Strategy & Business Development at BioArctic AB.
Ms. Lind holds an MBA from Columbia Business School and an undergraduate degree from The Leonard N Stern School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
XSPRAY PHARMA AB
0,02% | 02/05/2024 | 5 332 ( 0,02% ) | 40 480 $ | 30/06/2024 |
Postes actifs de Christine Lind
| Sociétés | Poste | Début |
|---|---|---|
| XSPRAY PHARMA AB | Directeur/Membre du Conseil | 01/01/2019 |
| MENDUS AB | Président | 22/01/2021 |
| BACTIGUARD HOLDING AB | Directeur Général | 12/04/2024 |
Lind Growth Strategy AB
 Lind Growth Strategy AB Miscellaneous Commercial ServicesCommercial Services Lind Growth Strategy AB is a private company that provides life science consulting services. The CEO of the Swedish company is Christine Lind. | Directeur Général | - |
NDA Group AB
 NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Corporate Officer/Principal | 01/04/2021 |
| Shinka Life Sciences AB | Corporate Officer/Principal | - |
Anciens postes connus de Christine Lind
| Sociétés | Poste | Fin |
|---|---|---|
| MEDIVIR AB | Directeur Général | 15/10/2018 |
| BIOARCTIC AB | Corporate Officer/Principal | - |
| Medivir Personal AB | Directeur/Membre du Conseil | - |
| ░░░░░░░░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Christine Lind
| Columbia Business School | Masters Business Admin |
| The Leonard N Stern School of Business | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| MEDIVIR AB | Health Technology |
| BIOARCTIC AB | Health Technology |
| XSPRAY PHARMA AB | Health Technology |
| MENDUS AB | Health Technology |
| BACTIGUARD HOLDING AB | Health Technology |
| Entreprise privées | 6 |
|---|---|
LifeCell Corp.
 LifeCell Corp. BiotechnologyHealth Technology LifeCell Corp. develops and markets tissue repair products. The firm focuses on reconstructive, urogynecologic and orthopedic surgical procedures. Its products include alloderm, strattice, graft jacket, allocraftdbm and repliform. The company was founded in 1986 and is headquartered in Branchburg, NJ. | Health Technology |
NDA Group AB
NDA Group AB Miscellaneous Commercial ServicesCommercial Services NDA Group AB provides drug developmental consultancy services to the pharmaceutical industry. It focuses on all phases of development and therapeutic areas such as pre-submission, submission, assessment, post authorization, regulatory, pharmacovigilance, and health technology assessment. The company was founded in 1997 and is headquartered in Upplands Väsby, Sweden. | Commercial Services |
| Medivir Personal AB | |
| Glycovisc BioTech AB | |
Lind Growth Strategy AB
Lind Growth Strategy AB Miscellaneous Commercial ServicesCommercial Services Lind Growth Strategy AB is a private company that provides life science consulting services. The CEO of the Swedish company is Christine Lind. | Commercial Services |
| Shinka Life Sciences AB |
